A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes.Published in:2012By:Bergenstal RM;Rosenstock J;Arakaki RF;Prince MJ;Qu Y;Sinha VP;Howey DC;Jacober SJ;Bergenstal, Richard M;Rosenstock, Julio;Arakaki, Richard F;Prince, Melvin J;Qu, Yongming;Sinha, Vikram P;Howey, Daniel C;Jacober, Scott JPublication type:journal article